About 30,000 Trademarks found for “vitys design di vitali matteo”

The mark consists of the letter "M" in a stylized font above the terms "MATTEO DINI" in a stylized font above the letters "MD" in a stylized font.

The English translation of the word "MATTEO" in the mark is Matthew.

In the statement, column 1, before line 1, MRG(2008) LLC (Limited Liability Company) 502 Rex Corp Plaza, Uniondale, NY 11566 is inserted.

The English translation of "SAN MATTEO" in the mark is "Saint Matthew".

Entertainment services, namely, organizing, arranging, and hosting social entertainment events; entertainment services, namely, live music concerts and live show performances; organizing community sporting and cultural events; dance club entertainment services; discotheque services; night club services; party, ball and special event planning for entertainment purposes; organization, arrangement and conducting of social entertainment events; providing facilities for educational seminars; provision of information, advice and consultancy in relation to all the aforementioned

Musical recordings

Color is not claimed as a feature of the mark.

The name(s), portrait(s), and/or signature(s) shown in the mark identifies Matteo Isaiah Buford-Diaz, whose consent(s) to register is made of record.

The wording "MATTEOBENNI" has no meaning in a foreign language.

The name(s), portrait(s), and/or signature(s) shown in the mark identifies Matthew J. Sánchez, whose consent(s) to register is made of record.

Scientific research services for others in the field of peptide and protein design based upon advanced knowledge in structural biology, molecular biology, and immunology for the benefit of others; Scientific research and development of novel host peptide and protein-based therapeutics for the treatment of plant and human diseases; Scientific research and development of novel host peptide and protein-based therapeutics for the treatment of Pierce's Disease in grapes and Huanglongbing in citrus; Scientific research and development of novel host peptide and protein-based therapeutics for the treatment of Coronavirus disease 2019 and Alzheimer's disease in humans; Scientific research and development of novel host peptide and protein-based therapeutics that enhance host immune responses in plant and animals